Ortho Regenerative Technologies received an EU Notice of Allowance from the European Patent Office for Patent Application Number 10831000.4, Novel Forumulation of Physiological Chitosan-Inorganic Salt Solution/Blood Mixtures for Tissue Repair. When issued, the patent will protect the composition of Ortho-R biopolymer material for the biologic repair of tissue.
This derives from the company's second series of patent applications for its propriety biopolymer platform, globally. Ortho-R is in development for the repair of rotator cuff tendons, meniscus and articular cartilage. The polymer can be directly placed into an injury site during a routine procedure, reportedly without significant additional time of the surgery.
Sources: Ortho Regenerative Technologies Inc.; ORTHOWORLD Inc.